Search Results - Isabelle Treilleux

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Activation of rapid oestrogen signalling in aggressive human breast cancers by Coralie Poulard, Isabelle Treilleux, Emilie Lavergne, Katia Bouchekioua‐Bouzaghou, Sophie Goddard‐Léon, Sylvie Chabaud, Olivier Trédan, Laura Corbo, Muriel Le Romancer

    Published in EMBO Molecular Medicine (2012-10-01)
    Get full text
    Article


  2. 2

    Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca2+ traffic and response to neoadjuvant chemotherapy by Minh Quang Duong, Rudy Gadet, Isabelle Treilleux, Stéphane Borel, Adrien Nougarède, Olivier Marcillat, Philippe Gonzalo, Ivan Mikaelian, Nikolay Popgeorgiev, Ruth Rimokh, Germain Gillet

    Published in Cell Death and Disease (2023-07-01)
    Get full text
    Article


  3. 3

    Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancer by Sonia Brahim, Ana-Maria Negulescu, Clara Geneste, Thomas Schott, Shuheng Lin, Louis-Oscar Morel, Nicolas Rama, Nicolas Gadot, Isabelle Treilleux, Patrick Mehlen, Olivier Meurette

    Published in Cell Death and Disease (2023-02-01)
    Get full text
    Article


  4. 4

    Combining chemotherapeutic agents and netrin‐1 interference potentiates cancer cell death by Andrea Paradisi, Marion Creveaux, Benjamin Gibert, Guillaume Devailly, Emeline Redoulez, David Neves, Elsa Cleyssac, Isabelle Treilleux, Christian Klein, Gerhard Niederfellner, Philippe A. Cassier, Agnès Bernet, Patrick Mehlen

    Published in EMBO Molecular Medicine (2013-10-01)
    Get full text
    Article


  5. 5

    Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer by Coralie Poulard, Thuy Ha Pham, Youenn Drouet, Julien Jacquemetton, Ausra Surmielova, Loay Kassem, Benoite Mery, Christine Lasset, Jonathan Reboulet, Isabelle Treilleux, Elisabetta Marangoni, Olivier Trédan, Muriel Le Romancer

    Published in EMBO Molecular Medicine (2023-07-01)
    Get full text
    Article


  6. 6

    BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges by Laetitia Collet, Laetitia Collet, Laetitia Collet, Brunhilde Hanvic, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolas Chopin, Olivia Le Saux, Olivia Le Saux, Isabelle Ray-Coquard, Isabelle Ray-Coquard

    Published in Frontiers in Oncology (2024-03-01)
    Get full text
    Article


  7. 7

    Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1 by Elise Berthel, Anne Vincent, Lauriane Eberst, Adrian Gabriel Torres, Estelle Dacheux, Catherine Rey, Virginie Marcel, Hermes Paraqindes, Joël Lachuer, Frédéric Catez, Lluis Ribas de Pouplana, Isabelle Treilleux, Jean-Jacques Diaz, Nicole Dalla Venezia

    Published in Cells (2020-04-01)
    Get full text
    Article


  8. 8

    Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodies by Antonio Farina, Elise Peter, Nolwenn Billet, Macarena Villagrán-García, Véronique Rogemond, Celeste Nicola, Isabelle Treilleux, Le-Duy Do, Marie Benaiteau, Géraldine Picard, David Meyronet, Daniel Pissaloux, Marine Villard, Valentin Wucher, Jérôme Honnorat, Bastien Joubert, Virginie Desestret

    Get full text
    Article


  9. 9

    Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy by Olivia Le Saux, Renaud Sabatier, Isabelle Treilleux, Léa-Isabelle Renaud, Pierre-Emmanuel Brachet, Alejandra Martinez, Jean-Sébastien Frenel, Cyril Abdeddaim, Justine Berthet, Sarah Barrin, Amélie Colombe-Vermorel, Laetitia Odeyer, Alexandra Lainé, Christophe Caux, Bertrand Dubois, Isabelle Ray-Coquard

    Published in Therapeutic Advances in Medical Oncology (2025-08-01)
    Get full text
    Article


  10. 10

    MDR1-expressing CD4+ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response by Christophe Caux, Olivier Tredan, Thomas Duhen, Christine Ménétrier-Caux, Raphael Schneider, Laurie Besson, Isabelle Treilleux, Yenkel Grinberg-Bleyer, Anthony Di Roio, Margaux Hubert, Marion Bossennec, Céline Rodriguez, Guilhem Lalle, Lyvia Moudombi, Cyril Degletagne, Daniel J Campbell, Séverine Metzger

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Get full text
    Article


  11. 11

    Disequilibrium of BMP2 Levels in the Breast Stem Cell Niche Launches Epithelial Transformation by Overamplifying BMPR1B Cell Response by Marion Chapellier, Elodie Bachelard-Cascales, Xenia Schmidt, Flora Clément, Isabelle Treilleux, Emmanuel Delay, Alexandre Jammot, Christine Ménétrier-Caux, Gaëtan Pochon, Roger Besançon, Thibault Voeltzel, Claude Caron de Fromentel, Christophe Caux, Jean-Yves Blay, Richard Iggo, Véronique Maguer-Satta

    Published in Stem Cell Reports (2015-02-01)
    Get full text
    Article


  12. 12

    Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death by François Virard, Stéphane Giraud, Mélanie Bonnet, Léa Magadoux, Laetitia Martin, Thuy Ha Pham, Najwa Skafi, Sophie Deneuve, Rita Frem, Bruno O. Villoutreix, Nawal Hajj Sleiman, Jonathan Reboulet, Samir Merabet, Vincent Chaptal, Cédric Chaveroux, Nader Hussein, Nicolas Aznar, Tanguy Fenouil, Isabelle Treilleux, Pierre Saintigny, Stéphane Ansieau, Serge Manié, Serge Lebecque, Toufic Renno, Isabelle Coste

    Published in Nature Communications (2024-08-01)
    Get full text
    Article


  13. 13

    HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer by Qing Wang, Maha Ayyoub, Olivia Le Saux, Paola Bonaventura, Isabelle Treilleux, Nicolas Chopin, Clarisse Dubois, Virginie Mutez, Nicolas Chuvin, Yann Estornes, Jenny Valladeau-Guilemond, Stephane Depil, Nicolas Gadot, Marie Michelas, Audrey Page, Olivier Tabone, Marie Delles, Sarah Moran, Thibault Richard, Marjorie Lacourrège, Dina M Tawfik, Ema Etchegaray, Adrian Valente, Rasha E Boulos, Gabriel Jimenez Dominguez

    Published in Journal for ImmunoTherapy of Cancer (2025-08-01)
    Get full text
    Article


  14. 14

    Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial by Isabelle L. Ray-Coquard, Aude-Marie Savoye, Camille Schiffler, Marie-Ange Mouret-Reynier, Olfa Derbel, Elsa Kalbacher, Marianne LeHeurteur, Alejandra Martinez, Corina Cornila, Mathilde Martinez, Leila Bengrine Lefevre, Frank Priou, Nicolas Cloarec, Laurence Venat, Frédéric Selle, Dominique Berton, Olivier Collard, Elodie Coquan, Olivia Le Saux, Isabelle Treilleux, Sophie Gouerant, Antoine Angelergues, Florence Joly, Olivier Tredan

    Published in Nature Communications (2024-07-01)
    Get full text
    Article


  15. 15

    Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort by Thomas Grinda, Natacha Joyon, Amélie Lusque, Sarah Lefèvre, Laurent Arnould, Frédérique Penault-Llorca, Gaëtan Macgrogan, Isabelle Treilleux, Anne Vincent-Salomon, Juliette Haudebourg, Aurélie Maran-Gonzalez, Emmanuelle Charafe-Jauffret, Coralie Courtinard, Camille Franchet, Véronique Verriele, Etienne Brain, Patrick Tas, Cécile Blanc-Fournier, Agnès Leroux, Delphine Loussouarn, Anca Berghian, Eva Brabencova, Jean Pierre Ghnassia, Jean-Yves Scoazec, Suzette Delaloge, Thomas Filleron, Magali Lacroix-Triki

    Published in npj Breast Cancer (2021-04-01)
    Get full text
    Article


  16. 16

    Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma by Olivia Le Saux, Maude Ardin, Justine Berthet, Sarah Barrin, Morgane Bourhis, Justine Cinier, Yasmine Lounici, Isabelle Treilleux, Pierre-Alexandre Just, Guillaume Bataillon, Aude-Marie Savoye, Marie-Ange Mouret-Reynier, Elodie Coquan, Olfa Derbel, Louis Jeay, Suliman Bouizaguen, Intidhar Labidi-Galy, Séverine Tabone-Eglinger, Anthony Ferrari, Emilie Thomas, Christine Ménétrier-Caux, Eric Tartour, Isabelle Galy-Fauroux, Marc-Henri Stern, Magali Terme, Christophe Caux, Bertrand Dubois, Isabelle Ray-Coquard

    Published in Nature Communications (2024-07-01)
    Get full text
    Article


Search Tools: